• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

drugdelivery

Mylan CEO to testify before House panel over EpiPen pricing

September 14, 2016 By drugdelivery

Mylan

(Reuters) –Mylan (NSDQ:MYL) Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its EpiPen emergency allergy treatment, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday. Mylan has been widely criticized, including by U.S. Democratic presidential candidate Hillary Clinton, for sharply raising the price […]

Filed Under: Drug-Device Combinations, Legal News, Wall Street Beat Tagged With: Mylan

Novocure touts data from Optune-paclitaxel combination study

September 2, 2016 By drugdelivery

By Sarah Faulkner NovoCure (NSDQ:NVCR) announced yesterday that its ‘tumor treating fields, combined with the drug paclitaxel, are effective against ovarian cancer, the 5th most-common cause of cancer death in women in the US. The St. Helier, N.J.-based company won FDA approval in July for the Optune device to treat a type of brain cancer called glioblastoma. TTFields […]

Filed Under: Clinical Trials, Drug-Device Combinations, Oncology Tagged With: NovoCure

PharmaJet inks pact with World Health Organization for polio vaccine

August 31, 2016 By drugdelivery

By Sarah Faulkner PharmaJet said yesterday that it inked a multi-year partnership as part of the World Health Organization’s effort to eradicate polio, using the Colorado-based company’s needle-free technology. Their Tropis device administers medication through the skin, without the use of needles. Although polio has been eradicated from the Americas, Europe, South East Asia and the Western […]

Filed Under: Drug-Device Combinations Tagged With: PharmaJet, Polio, World Health Organization

MIT, Singapore Univ. dev 3-D-printed structures that “remember” their shapes

August 26, 2016 By drugdelivery

By Sarah Faulkner Engineers from MIT and Singapore University of Technology and Design are using light to create 3D structures that remember their shape when triggered by external stimuli like temperature. These structures, also known as shape-memory polymers, could be useful as delivery vessels for drugs in the human body. Get the full story at […]

Filed Under: Drug-Device Combinations, Materials Testing, Research & Development Tagged With: Massachusetts Institute of Technology

Mylan cuts EpiPen price in half after criticism

August 25, 2016 By drugdelivery

By Sarah Faulkner Mylan (NSDQ:MYL) said today that it would reduce the out-of-pocket patient cost for its EpiPen product, after being widely criticized for raising the price nearly 500% since 2009. Although the list price for the epinephrine injector remains the same, Mylan said it would increase eligibility for its patient assistance program, which eliminates out-of-pocket costs for uninsured […]

Filed Under: Drug-Device Combinations, Wall Street Beat Tagged With: Capitol Hill, Mylan

FDA request delays timeline for Sanofi’s iGlarLixi drug-device combo for diabetes

August 24, 2016 By drugdelivery

By Sarah Faulkner The FDA’s request for more data on the iGlarLixi drug-device combination for treating Type II diabetes pushed the timeline for a decision back 3 months, Sanofi (NYSE:SNY) and Zealand Pharma (CPH:ZEAL) said last week. Sanofi said August 19 that it submitted a new data package for iGlarLixi, an injection pen designed to […]

Filed Under: Diabetes, Drug-Device Combinations, Food & Drug Administration (FDA) Tagged With: Sanofi-Aventis, Zealand Pharma

Researchers debut digestible battery

August 24, 2016 By drugdelivery

By Sarah Faulkner Researchers at Carnegie Mellon University unveiled an ingestible battery that could eventually power medical devices, including drug-delivery mechanisms. The inspiration came when Christopher Bettinger, PhD, and his team noted that melanin pigments bind and unbind metallic ions. “We thought, ‘This is just like a battery,’” Bettinger said. The melanin pigments are encapsulated […]

Filed Under: Drug-Device Combinations Tagged With: Carnegie Mellon

Sirtex Medical jumps on surging sales, profits for fiscal 2016

August 24, 2016 By drugdelivery

By Sarah Faulkner Shares in Sirtex Medical (ASX:SRX) closed up nearly 12% today after the Australian medical device company posted huge boosts to both the bottom and top lines. Sydney-based Sirtex Medical makes targeted liver cancer therapies using resin microspheres called SIR-sphere Y-90. Sirtex said profits were $40.8 million (A$53.6 million), or 70¢ (A92.2¢) per share, on sales of […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Oncology, Wall Street Beat Tagged With: Sirtex Medical

Senators press Mylan on EpiPen price hike

August 24, 2016 By drugdelivery

By Sarah Faulkner UPDATED August 24, 2016, with comment from Hilary Clinton. Sens. Amy Klobuchar (D-Minn.) and Charles Grassley (R-Iowa) are pressing Mylan (NSDQ:MYL) for information on its 400% price increase for the EpiPen epinephrine auto-injector, which went from $100 in 2008 to more than $500 despite stable manufacturing costs. The pressure comes amid a nationwide […]

Filed Under: Drug-Device Combinations, Wall Street Beat Tagged With: Capitol Hill, Mylan

Amgen 2nd-quarter profit tops Street view, raises 2016 forecast

July 27, 2016 By drugdelivery

(Reuters) – Amgen (NSDQ:AMGN) on Wednesday reported higher-than-expected 2nd-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company again raised its full-year forecast. The forecast appeared to signal management’s confidence in the 2nd half of the year. The company is on track to meet or exceed its long-term objectives,” Chief […]

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: Amgen

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 11
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS